How FDA and 23andMe Dance Around Evidence That Is Not There

How FDA and 23andMe Dance Around Evidence That Is Not There

On July 20, 2010, Andrew Alexander, founder and director of easyDNA, received a letter from the US Food and Drug Administration. The FDA had noticed that easyDNA was marketing the "Genetic Predisposition Health Test, a home-use device that is 

7
Like
Save

Comments

Write a comment

*